- Home
- ACRV vs EAF Comparison
ACRV vs EAF Comparison
Compare ACRV & EAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- EAF
- Stock Information
- Founded
- ACRV 2018
- EAF 1886
- Country
- ACRV United States
- EAF United States
- Employees
- ACRV N/A
- EAF N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- EAF Industrial Machinery/Components
- Sector
- ACRV Health Care
- EAF Energy
- Exchange
- ACRV Nasdaq
- EAF Nasdaq
- Market Cap
- ACRV 247.8M
- EAF 215.0M
- IPO Year
- ACRV 2022
- EAF 1995
- Fundamental
- Price
- ACRV $7.93
- EAF $2.15
- Analyst Decision
- ACRV Strong Buy
- EAF Hold
- Analyst Count
- ACRV 5
- EAF 5
- Target Price
- ACRV $22.60
- EAF $1.75
- AVG Volume (30 Days)
- ACRV 44.0K
- EAF 1.7M
- Earning Date
- ACRV 11-13-2024
- EAF 11-12-2024
- Dividend Yield
- ACRV N/A
- EAF N/A
- EPS Growth
- ACRV N/A
- EAF N/A
- EPS
- ACRV N/A
- EAF N/A
- Revenue
- ACRV N/A
- EAF $541,710,000.00
- Revenue This Year
- ACRV N/A
- EAF N/A
- Revenue Next Year
- ACRV N/A
- EAF $15.79
- P/E Ratio
- ACRV N/A
- EAF N/A
- Revenue Growth
- ACRV N/A
- EAF N/A
- 52 Week Low
- ACRV $3.19
- EAF $0.52
- 52 Week High
- ACRV $11.90
- EAF $2.76
- Technical
- Relative Strength Index (RSI)
- ACRV 48.40
- EAF 64.73
- Support Level
- ACRV $7.69
- EAF $1.84
- Resistance Level
- ACRV $8.66
- EAF $2.19
- Average True Range (ATR)
- ACRV 0.34
- EAF 0.24
- MACD
- ACRV -0.00
- EAF 0.00
- Stochastic Oscillator
- ACRV 22.64
- EAF 55.75
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About EAF GrafTech International Ltd.
GrafTech International Ltd is a manufacturer of high-quality graphite electrode products essential to the production of EAF steel and other ferrous and non-ferrous metals. The company has only reportable segment, Industrial Materials, is comprised of its two major product categories: graphite electrodes and petroleum needle coke products. Petroleum needle coke is key raw material used in the production of graphite electrodes.